Core Laboratories N.V.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CLB research report →
Range $21 – $21
Price Chart
About the company
Core Laboratories N. V. (CLB) is a global provider to the oil and gas sector, delivering specialized services and products for characterizing subterranean reservoirs and optimizing hydrocarbon extraction.
- CEO
- Lawrence V. Bruno
- IPO
- 1995
- Employees
- 3,300
- HQ
- Houston, TX, US
Get TickerSpark's AI analysis on CLB
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $355.59M
- P/E
- 24.68
- Fwd P/E
- 16.02
- PEG
- -0.49
- P/S
- 0.74
- P/B
- 1.41
- EV/EBITDA
- 9.74
- Div Yield
- 0.48%
- Gross Margin
- 17.67%
- Op Margin
- 7.57%
- Net Margin
- 3.01%
- ROE
- 5.73%
- ROIC
- 4.38%
Latest fiscal year · YoY change
- Revenue
- $526.52M+0.5%
- Gross Profit
- $94.28M+6.7%
- Op Income
- $50.49M
- Net Income
- $29.67M-5.5%
- EPS
- $0.68+1.5%
- OCF Growth
- -34.3%
- FCF Growth
- -48.6%
- 52W High
- $20.36
- 52W Low
- $7.71
- 50D MA
- $10.05
- 200D MA
- $13.14
- Beta
- 1.17
- RSI (14)
- 25
- Avg Volume
- 612.41K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Core Laboratories delivered better sequential Q3 results, but geopolitical disruptions in the Middle East and Russia/Ukraine continued to weigh on year-over-year comparisons and near-term visibility.· October 29, 2026
- Q3 revenue was $132.1 million, up 6% sequentially and down 2% year over year; adjusted EPS was $0.16 versus $0.11 last quarter and $0.22 a year ago.
- Reservoir Description improved sharply sequentially, with revenue of $84.3 million and adjusted operating income of $8.1 million, lifting margins to 10% from 5% in Q2.
- Production Enhancement revenue reached $47.8 million, up 4% sequentially and 3% year over year, but margins eased because sales mix shifted toward lower-margin product sales.
- The company bought back about 88,000 shares for $1.1 million and said this was the eighth consecutive quarter of share repurchases.
- Q4 guidance calls for revenue of $128.5 million to $134.5 million, adjusted EPS of $0.12 to $0.20, and operating margin of 10%.
Third-quarter 2026 revenue was $132.1 million, up 6% sequentially and down 2% year over year. Adjusted EPS was $0.16, versus $0.11 in Q2 and $0.22 in Q3 2025; GAAP EPS was $0.12. Adjusted EBIT was $12.6 million, with margin of approximately 10%, up 200 basis points sequentially. Reservoir Description revenue was $84.3 million, up 7% sequentially, with adjusted operating income of $8.1 million and 10% margin; Production Enhancement revenue was $47.8 million, up 4% sequentially and 3% year over year, with adjusted operating income of $4.4 million and margins over 9%. Cash flow from operations was $5 million, free cash flow was $1.7 million after $3.3 million of CapEx for operations, and share repurchases totaled approximately 88,000 shares for $1.1 million. For full-year 2026, management expects G&A ex-items of about $43 million to $45 million and capital expenditures of $14 million to $16 million excluding rebuilding the U.K. facility. Fourth-quarter 2026 guidance is revenue of $128.5 million to $134.5 million, operating income of $10.7 million to $15.1 million, operating margin of 10%, and EPS of $0.12 to $0.20.
Larry Bruno framed the quarter as a sequential improvement despite ongoing geopolitical disruption. He emphasized Core’s long-term strategy of investing in technologies, maintaining a lean organization, and returning excess free cash to shareholders through dividends, debt reduction, and opportunistic buybacks. His tone was cautiously optimistic, with a focus on long-cycle international spending and the company’s ability to serve clients through uncertainty.
Chris Hill highlighted the main financial drivers and the quarter’s adjusted figures, including revenue of $132.1 million, adjusted EBIT of $12.6 million, adjusted net income of $7.4 million, and adjusted EPS of $0.16. He said service revenue was $96 million and product sales were $36.1 million, with product sales up 19% sequentially; he also noted cost of services ex-items at 78% of service revenue and cost of sales ex-items at 83% of revenue. On the balance sheet, he cited long-term debt of $114.8 million, cash of $21.4 million, net debt of $93.4 million, and leverage just under 1.5. He also said the company expects 2026 G&A ex-items of $43 million to $45 million and full-year CapEx of $14 million to $16 million excluding the U.K. rebuild.
In Q&A, Josh Jayne asked where management expects 2027 spending to increase and whether the uplift is region-specific or broad-based. Larry Bruno said conversations with clients point to a global increase in capital spending, mainly tied to long-cycle projects that should be less sensitive to short-term oil price swings. Jayne also asked about U.S. Production Enhancement demand, and management said the recent uptick has mostly come from smaller private operators, while larger publics appear likely to spend roughly to budget rather than increase activity materially.
Management described a broadening global capex backdrop for 2027 and said long-cycle international projects appear to be gaining traction. Core also showed sequential operating improvement, stronger product demand in both U.S. and international markets, and continued success winning projects and contracts tied to its proprietary technologies.
The biggest risk on the call was ongoing geopolitical disruption in the Middle East and Russia/Ukraine, which is still delaying projects, disrupting logistics, and pressuring crude assay and service work. Management also flagged year-over-year margin and revenue pressure in some areas, weak visibility on Middle East recovery timing, and only modest near-term U.S. land demand from larger operators who are not flexing budgets much.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 98.6%
- Shares Outstanding
- 45.82M
- Float Shares
- 45.17M
of shares held by institutions
191 13F filers
Buy/sell ratio 0.50. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for CLB, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Shelley Moore CapitoSenate · WV | Sell | Apr 24, 18 | Filing → |
| Thomas J. RooneyHouse · FL17 | Sell | Dec 10, 18 | Filing → |
| Thomas Charles MacArthurHouse · NJ03 | Sell | Oct 23, 18 | Filing → |
| Thomas Charles MacArthurHouse · NJ03 | Sell | Oct 24, 18 | Filing → |
| Thomas Charles MacArthurHouse · NJ03 | Buy | Jun 7, 18 | Filing → |
| Shelley Moore CapitoSenate · WV | Sell | Apr 24, 18 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Ariel Investments, LLC | 14.06M | ▼ 14.55K |
| Blackrock, Inc. | 4.51M | ▼ 2.95M |
| Vanguard Group Inc | 3.08M | ▲ 32.49K |
| Disciplined Growth Investors Inc /Mn | 3.04M | ▼ 1.89M |
| Earnest Partners LLC | 2.63M | ▼ 311.37K |
| Dimensional Fund Advisors LP | 1.62M | ▲ 69.97K |
| Vanguard Capital Management LLC | 1.58M | ▼ 12.36K |
| State Street Corp | 1.56M | ▼ 619.09K |
| Schroder Investment Management Group | 1.54M | ▲ 1.54M |
| Gendell Jeffrey L | 1.38M | ▲ 289.56K |
| Heartland Advisors Inc | 1.12M | ▲ 61.59K |
| Geode Capital Management, LLC | 1.09M | ▼ 106.35K |
Held by 233 ETFs
Biggest fund positions in CLB by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 1, 26 | Tattoli Mark Damian | other | 700 |
| Oct 1, 26 | Tattoli Mark Damian | other | 276 |
| Oct 1, 26 | Tattoli Mark Damian | other | 700 |
| Oct 1, 26 | Teo Sow Hang | other | 250 |
| Oct 1, 26 | Teo Sow Hang | other | 99 |
| Oct 1, 26 | Teo Sow Hang | other | 250 |
| Jul 31, 26 | Bruno Lawrence | buy | 5,000 |
| Aug 1, 26 | Teo Sow Hang | other | 240 |
| Aug 1, 26 | Teo Sow Hang | other | 108 |
| Aug 1, 26 | Teo Sow Hang | other | 200 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CLB coverage
Recent articles, reports, and earnings notes.
No research on CLB yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CLB report →CLB Q3 Earnings Miss Estimates on Higher Costs and Disruptions
zacks.com · Nov 3
Core Laboratories Q3 Earnings Call Highlights
marketbeat.com · Oct 30
Core Laboratories Inc. (CLB) Q3 2026 Earnings Call Transcript
seekingalpha.com · Oct 29
Core Laboratories (CLB) Q3 Earnings Miss Estimates
zacks.com · Oct 28
CORE LAB REPORTS THIRD QUARTER 2026 RESULTS:
prnewswire.com · Oct 28
CORE LABORATORIES ANNOUNCES TIMING OF THIRD QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL
prnewswire.com · Oct 1
CLB Declines 35% in the Past Six Months: How to Play the Stock?
zacks.com · Sep 22
Top 3 Energy Stocks You'll Regret Missing In September
benzinga.com · Sep 17
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.